Literature DB >> 21682835

Anabolic steroids and male infertility: a comprehensive review.

Guilherme Leme de Souza1, Jorge Hallak.   

Abstract

What's known on the subject? and What does the study add? The negative impact of AAS abuse on male fertility is well known by urologists. The secondary hypogonadotropic hypogonadism is often highlighted when AAS and fertility are being discussed. On the other hand, the patterns of use, mechanisms of action and direct effects over the testicle are usually overseen. The present study reviews the vast formal and "underground" culture of AAS, as well as their overall implications. Specific considerations about their impact on the male reproductive system are made, with special attention to the recent data on direct damage to the testicle. To our knowledge this kind of overview is absolutely unique, offering a distinguished set of information to the day-by-day urologists. For several decades, testosterone and its synthetic derivatives have been used with anabolic and androgenic purposes. Initially, these substances were restricted to professional bodybuilders, becoming gradually more popular among recreational power athletes. Currently, as many as 3 million anabolic-androgenic steroids (AAS) users have been reported in the United States, and considering its increasing prevalence, it has become an issue of major concern. Infertility is defined as the failure to achieve a successful pregnancy after 12 months or more of regular unprotected intercourse, with male factor being present in up to 50% of all infertile couples. Several conditions may be related to male infertility. Substance abuse, including AAS, is commonly associated to transient or persistent impairment on male reproductive function, through different pathways. Herein, a brief overview on AAS, specially oriented to urologists, is offered. Steroids biochemistry, patterns of use, physiological and clinical issues are enlightened. A further review about fertility outcomes among male AAS abusers is also presented, including the classic reports on transient axial inhibition, and the more recent experimental reports on structural and genetic sperm damage.
© 2011 THE AUTHORS. BJU INTERNATIONAL © 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21682835     DOI: 10.1111/j.1464-410X.2011.10131.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  45 in total

Review 1.  Evaluation of the azoospermic male.

Authors:  Robert Oates
Journal:  Asian J Androl       Date:  2011-12-19       Impact factor: 3.285

Review 2.  Andrological aspects of physical exercise and sport medicine.

Authors:  Luigi Di Luigi; Francesco Romanelli; Paolo Sgrò; Andrea Lenzi
Journal:  Endocrine       Date:  2012-03-20       Impact factor: 3.633

3.  Is semen analysis necessary prior to the commencement of testosterone supplementation therapy in men of reproductive age?

Authors:  Michael Pan; Ranjith Ramasamy; Jason R Kovac
Journal:  Can Urol Assoc J       Date:  2014-11       Impact factor: 1.862

Review 4.  Supraphysiologic-dose anabolic-androgenic steroid use: A risk factor for dementia?

Authors:  Marc J Kaufman; Gen Kanayama; James I Hudson; Harrison G Pope
Journal:  Neurosci Biobehav Rev       Date:  2019-02-25       Impact factor: 8.989

Review 5.  Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.

Authors:  Harrison G Pope; Ruth I Wood; Alan Rogol; Fred Nyberg; Larry Bowers; Shalender Bhasin
Journal:  Endocr Rev       Date:  2013-12-17       Impact factor: 19.871

6.  Cynara scolymus leaves extract alleviates nandrolone decanoate-induced alterations in testicular function and sperm quality in albino rats.

Authors:  Eman Taha Mohammed; Abeer M Radi; Lotfi Aleya; Mohamed M Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2019-12-16       Impact factor: 4.223

7.  Men's knowledge of their own fertility: a population-based survey examining the awareness of factors that are associated with male infertility.

Authors:  D Daumler; P Chan; K C Lo; J Takefman; P Zelkowitz
Journal:  Hum Reprod       Date:  2016-11-05       Impact factor: 6.918

Review 8.  Novel Uses for the Anabolic Androgenic Steroids Nandrolone and Oxandrolone in the Management of Male Health.

Authors:  Christopher Wu; Jason R Kovac
Journal:  Curr Urol Rep       Date:  2016-10       Impact factor: 3.092

Review 9.  Illicit use of androgens and other hormones: recent advances.

Authors:  Gen Kanayama; Harrison G Pope
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-06       Impact factor: 3.243

10.  Recombinant production of enzymatically active male contraceptive drug target hTSSK2 - Localization of the TSKS domain phosphorylated by TSSK2.

Authors:  Jagathpala Shetty; Rondedrick Sinville; Igor A Shumilin; Wladek Minor; Jianhai Zhang; Jon E Hawkinson; Gunda I Georg; Charles J Flickinger; John C Herr
Journal:  Protein Expr Purif       Date:  2016-01-14       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.